Kush Parmar, Director, 10% Owner at Entrada Therapeutics, Inc. (TRDA), sold 54,000 shares at $7.50 ($405K) on 2025-07-09, disclosed to the SEC on 2025-07-11.
Open-market sale of $405k TRDA by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.50 | 6,935 | $52K | 12.8% |
| 2 | $7.50 | 6,935 | $52K | 12.8% |
| 3 | $7.50 | 20,065 | $150K | 37.2% |
| 4 | $7.50 | 20,065 | $150K | 37.2% |
| Total | $7.50 avg | 54,000 | $405K | 100% |
| Filing → |
| TRDA | SELL | 2025-11-18 | $3.5M | — | Filing → |
| TRDA | SELL | 2025-07-01 | $1.6M | — | Filing → |
| SKYE | BUY | 2024-03-15 | $4.5M | — | Filing → |